Institutional investors hold a majority ownership of CELG through the 76.28% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2018, these large investors purchased a net $39.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ORBIS INVESTMENT MANAGEMENT LTD. Bought 6.2 Million shares of Celgene Corp
D. E. SHAW & CO. LP Bought 3.5 Million shares of Celgene Corp
ARROWSTREET CAPITAL LP Bought 3.3 Million shares of Celgene Corp